“…Among B cells, a large number of these defects have been associated with HIV-induced immune activation, as evidenced by hypergammaglobulinemia, increased expression of B cell activation markers, decreased responsiveness to B cell stimuli, and increased susceptibility to oncogenesis (1)(2)(3). Several studies have demonstrated that after reduction of HIV plasma viremia by antiretroviral therapy, B cell abnormalities subside, especially those thought to be directly or indirectly associated with virus-induced aberrant immune activation (4)(5)(6). We have demonstrated previously both in longitudinal and cross-sectional analyses that overrepresentation of a distinct B cell population, defined by reduced expression of CD21 and increased secretion of immunoglobulins (7), is likely to be responsible for several of the B cell defects that have been associated with ongoing HIV replication (8)(9)(10).…”